First patients dosed in early trial for Hard-to-Treat cancers
NCT ID NCT07247110
Summary
This is a first-in-human study to test the safety and side effects of a new oral drug called MK-4716 for people with advanced solid tumors that have a specific genetic change called a KRAS alteration. The drug will be tested both by itself and in combination with other approved cancer therapies. The main goals are to find a safe dose and see how the drug moves through the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT NEOPLASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Asan Medical Center ( Site 0502)
RECRUITINGSeoul, 05505, South Korea
Contact Phone: •••-•••-••••
-
Bradfordhill ( Site 0102)
RECRUITINGSantiago, Region M. de Santiago, 8420383, Chile
Contact Phone: •••-•••-••••
-
Hospital Clinic de Barcelona ( Site 0362)
RECRUITINGBarcelona, 08036, Spain
Contact Phone: •••-•••-••••
-
Hospital General Universitari Vall d Hebron ( Site 0360)
RECRUITINGBarcelona, 08035, Spain
Contact Phone: •••-•••-••••
-
Hospital Universitario Fundacion Jimenez Diaz ( Site 0361)
RECRUITINGMadrid, 28040, Spain
Contact Phone: •••-•••-••••
-
NEXT Oncology ( Site 0051)
RECRUITINGIrving, Texas, 75039, United States
Contact Phone: •••-•••-••••
-
NEXT Virginia ( Site 0054)
RECRUITINGFairfax, Virginia, 22031, United States
Contact Phone: •••-•••-••••
-
One Clinical Research ( Site 0454)
RECRUITINGNedlands, Western Australia, 6009, Australia
Contact Phone: •••-•••-••••
-
Pontificia Universidad Catolica de Chile-CICUC ( Site 0103)
RECRUITINGSantiago, Region M. de Santiago, 8330073, Chile
Contact Phone: •••-•••-••••
-
Rabin Medical Center ( Site 0253)
RECRUITINGPetah Tikva, 4941492, Israel
Contact Phone: •••-•••-••••
-
Rambam Health Care Campus ( Site 0252)
RECRUITINGHaifa, 3109601, Israel
Contact Phone: •••-•••-••••
-
Rutgers Cancer Institute of New Jersey ( Site 0052)
RECRUITINGNew Brunswick, New Jersey, 08903, United States
Contact Phone: •••-•••-••••
-
Seoul National University Hospital ( Site 0501)
RECRUITINGSeoul, 03080, South Korea
Contact Phone: •••-•••-••••
-
Sheba Medical Center ( Site 0251)
RECRUITINGRamat Gan, 5265601, Israel
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.